TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

ACHROMYCIN V

TETRACYCLINE HYDROCHLORIDE
Infectious Disease Approved 1955-01-27
Jump to: Indications Approvals Trials Competitors Similar Safety Patents
3
Indications
--
Phase 3 Trials
71
Years on Market

Details

Status
Prescription
First Approved
1955-01-27
Routes
ORAL
Dosage Forms
CAPSULE, SUSPENSION

Companies

AVET LEDERLE
Active Ingredient: TETRACYCLINE HYDROCHLORIDE

ACHROMYCIN V Approval History

Loading approval history...

What ACHROMYCIN V Treats

9 indications

ACHROMYCIN V is approved for 9 conditions since its original approval in 1955. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Upper Respiratory Tract Infection
  • Lower Respiratory Tract Infection
  • Skin and Soft Tissue Infection
  • Rickettsial Infection
  • Rocky Mountain Spotted Fever
  • Typhus
  • Q Fever
  • Rickettsialpox
Source: FDA Label

Drugs Similar to ACHROMYCIN V

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

SUMYCIN
TETRACYCLINE HYDROCHLORIDE
9 shared
STRIDES PHARMA INTL
Shared indications:
Upper Respiratory Tract InfectionLower Respiratory Tract InfectionSkin and Soft Tissue Infection +6 more
ACTICLATE
DOXYCYCLINE HYCLATE
5 shared
CHARTWELL RX
Shared indications:
Rocky Mountain Spotted FeverTyphusQ Fever +2 more
DOXY 200
DOXYCYCLINE HYCLATE
5 shared
Fresenius Kabi
Shared indications:
Rocky Mountain Spotted FeverTyphusQ Fever +2 more
DOXYCYCLINE
DOXYCYCLINE
5 shared
Lupin
Shared indications:
Rocky Mountain Spotted FeverTyphusQ Fever +2 more
DOXYCYCLINE HYCLATE
DOXYCYCLINE HYCLATE
5 shared
PRINSTON INC
Shared indications:
Rocky Mountain Spotted FeverTyphusQ Fever +2 more
MONODOX
DOXYCYCLINE
5 shared
CHARTWELL RX
Shared indications:
Rocky Mountain Spotted FeverTyphusQ Fever +2 more
DOXY 100
DOXYCYCLINE HYCLATE
4 shared
Fresenius Kabi
Shared indications:
Rocky Mountain Spotted FeverTyphusQ Fever +1 more
BICILLIN C-R 900/300
PENICILLIN G BENZATHINE
2 shared
KING PHARMS LLC
Shared indications:
Upper Respiratory Tract InfectionSkin and Soft Tissue Infection
ERY-TAB
ERYTHROMYCIN
2 shared
PHARMOBEDIENT
Shared indications:
Upper Respiratory Tract InfectionLower Respiratory Tract Infection
ERYTHROMYCIN LACTOBIONATE
ERYTHROMYCIN LACTOBIONATE
2 shared
GLAND
Shared indications:
Upper Respiratory Tract InfectionLower Respiratory Tract Infection
PENICILLIN G PROCAINE
PENICILLIN G PROCAINE
2 shared
KING PHARMS LLC
Shared indications:
Upper Respiratory Tract InfectionSkin and Soft Tissue Infection
AMOXICILLIN PEDIATRIC
AMOXICILLIN
1 shared
Teva
Shared indications:
Lower Respiratory Tract Infection
ARIKAYCE KIT
AMIKACIN SULFATE
1 shared
INSMED INC
Shared indications:
Skin and Soft Tissue Infection
AUGMENTIN '125'
AMOXICILLIN
1 shared
US ANTIBIOTICS
Shared indications:
Lower Respiratory Tract Infection
AUGMENTIN '250'
AMOXICILLIN
1 shared
US ANTIBIOTICS
Shared indications:
Lower Respiratory Tract Infection
AUGMENTIN '875'
AMOXICILLIN
1 shared
US ANTIBIOTICS
Shared indications:
Lower Respiratory Tract Infection
AUGMENTIN XR
AMOXICILLIN
1 shared
US ANTIBIOTICS
Shared indications:
Lower Respiratory Tract Infection
AZACTAM
AZTREONAM
1 shared
Bristol-Myers Squibb
Shared indications:
Lower Respiratory Tract Infection
AZTREONAM
AZTREONAM
1 shared
Pfizer
Shared indications:
Lower Respiratory Tract Infection
CEFOTAN
CEFOTETAN DISODIUM
1 shared
PAI HOLDINGS PHARM
Shared indications:
Lower Respiratory Tract Infection
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

ACHROMYCIN V FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

To reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Tetracycline is indicated in the treatment of infe...

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: NDA050278 → Label: DailyMed → Patents: FDA Orange Book → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.